Intesa Sanpaolo SpA
XMUN:IES
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intesa Sanpaolo SpA
XMUN:IES
|
IT |
|
H
|
Hologic Inc
XMUN:HO1
|
US |
|
A
|
Abbott Laboratories
DUS:ABL
|
US |
|
C
|
China Petroleum & Chemical Corp
XMUN:CHU
|
CN |
|
D
|
Deutsche Bank AG
DUS:DBK
|
DE |
|
L
|
Lam Research Corp
XMUN:LAR
|
US |
|
P
|
Procter & Gamble Co
BMV:PG
|
US |
|
SGS SA
F:SUVN
|
CH |
|
K
|
Kuraray Co Ltd
DUS:KUY
|
JP |
Wall St Price Targets
IES Price Targets Summary
Intesa Sanpaolo SpA
According to Wall Street analysts, the average 1-year price target for IES is 7.135 EUR with a low forecast of 6.125 EUR and a high forecast of 8.078 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IES's stock price target?
Price Target
7.135
EUR
According to Wall Street analysts, the average 1-year price target for IES is 7.135 EUR with a low forecast of 6.125 EUR and a high forecast of 8.078 EUR.
What is the Revenue forecast for Intesa Sanpaolo SpA?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 5 years is -6%.
What is the Net Income forecast for Intesa Sanpaolo SpA?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 6%.
